Identification of natural compound inhibitors for substrate-binding site of MTHFD2 enzyme: Insights from structure-based drug design and biomolecular simulations
A computational structure-based drug design approach was employed to identify inhibitors targeting the active site of the MTHFD2 enzyme. From a virtual screening of 2,36,561 natural product molecules, 12,764 molecules were retrieved, and 3,277 unique molecules were screened. After drug-likeness and...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-06-01
|
| Series: | Chemical Physics Impact |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2667022424003530 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841555650146992128 |
|---|---|
| author | Nisarg Rana Priyanka Solanki Rukmankesh Mehra Anu Manhas |
| author_facet | Nisarg Rana Priyanka Solanki Rukmankesh Mehra Anu Manhas |
| author_sort | Nisarg Rana |
| collection | DOAJ |
| description | A computational structure-based drug design approach was employed to identify inhibitors targeting the active site of the MTHFD2 enzyme. From a virtual screening of 2,36,561 natural product molecules, 12,764 molecules were retrieved, and 3,277 unique molecules were screened. After drug-likeness and pharmacokinetic filtering, 209 molecules were docked into the active site of the enzyme, and 20 candidates were shortlisted based on docking score and crucial interactions with residues Asn87, Lys88, Gly310, and Gln132. HYDE (HYdrogen Bond and Dehydration Energies) analysis further refined the selection to eight promising molecules (C1-C8) with docking score ≥ -30.12 kcal/mol. Through 300 ns molecular dynamics simulations, key properties such as RMSD, RMSF, RoG, H-bond count and lifetime, SASA, PCA, FEL (2D and 3D), and DCCM were evaluated to predict the system stability. The protein-ligand interaction energy analysis revealed that compounds C3, C4, and C6 demonstrated the highest Coulombic energies (-211.58 kJ/mol, -113.25 kJ/mol, and -210.28 kJ/mol, respectively) and Lennard-Jones energies (-150.73 kJ/mol, -161.73 kJ/mol, and -127.70 kJ/mol, respectively), indicating strong binding energies. MM/PBSA free energy calculations supported these findings, with C3 (-33.26 kcal/mol) and C6 (-32.11 kcal/mol) displaying the strongest binding energies, while C5 (-20.59 kcal/mol) exhibited moderate binding affinity. The stability and compactness observed on RoG, H-bond analyses, and FEL results corroborate these binding energies profiles, reinforcing the selectivity and strength of these compounds. These findings demonstrated that compounds C3, C5, and C6 exhibit high stability, and strong binding interactions towards the MTHFD2 enzyme. By integrating multicomplex pharmacophore modeling, molecular dynamics, protein-ligand interaction energy analysis, and free energy calculations, this study offers a framework for identifying novel anticancer agents. |
| format | Article |
| id | doaj-art-05194cfde5fc4e9c969c17312ecb1997 |
| institution | Kabale University |
| issn | 2667-0224 |
| language | English |
| publishDate | 2025-06-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Chemical Physics Impact |
| spelling | doaj-art-05194cfde5fc4e9c969c17312ecb19972025-01-08T04:53:47ZengElsevierChemical Physics Impact2667-02242025-06-0110100809Identification of natural compound inhibitors for substrate-binding site of MTHFD2 enzyme: Insights from structure-based drug design and biomolecular simulationsNisarg Rana0Priyanka Solanki1Rukmankesh Mehra2Anu Manhas3Department of Chemistry, School of Energy Technology, Pandit Deendayal Energy University-382426, IndiaDepartment of Chemistry, School of Energy Technology, Pandit Deendayal Energy University-382426, IndiaDepartment of Chemistry, Indian Institute of Technology Bhilai, Bhilai, Durg-491002, Chhattisgarh, India; Department of Bioscience and Biomedical Engineering, Indian Institute of Technology Bhilai, Bhilai, Durg-491002, Chhattisgarh, IndiaDepartment of Chemistry, School of Energy Technology, Pandit Deendayal Energy University-382426, India; Corresponding author.A computational structure-based drug design approach was employed to identify inhibitors targeting the active site of the MTHFD2 enzyme. From a virtual screening of 2,36,561 natural product molecules, 12,764 molecules were retrieved, and 3,277 unique molecules were screened. After drug-likeness and pharmacokinetic filtering, 209 molecules were docked into the active site of the enzyme, and 20 candidates were shortlisted based on docking score and crucial interactions with residues Asn87, Lys88, Gly310, and Gln132. HYDE (HYdrogen Bond and Dehydration Energies) analysis further refined the selection to eight promising molecules (C1-C8) with docking score ≥ -30.12 kcal/mol. Through 300 ns molecular dynamics simulations, key properties such as RMSD, RMSF, RoG, H-bond count and lifetime, SASA, PCA, FEL (2D and 3D), and DCCM were evaluated to predict the system stability. The protein-ligand interaction energy analysis revealed that compounds C3, C4, and C6 demonstrated the highest Coulombic energies (-211.58 kJ/mol, -113.25 kJ/mol, and -210.28 kJ/mol, respectively) and Lennard-Jones energies (-150.73 kJ/mol, -161.73 kJ/mol, and -127.70 kJ/mol, respectively), indicating strong binding energies. MM/PBSA free energy calculations supported these findings, with C3 (-33.26 kcal/mol) and C6 (-32.11 kcal/mol) displaying the strongest binding energies, while C5 (-20.59 kcal/mol) exhibited moderate binding affinity. The stability and compactness observed on RoG, H-bond analyses, and FEL results corroborate these binding energies profiles, reinforcing the selectivity and strength of these compounds. These findings demonstrated that compounds C3, C5, and C6 exhibit high stability, and strong binding interactions towards the MTHFD2 enzyme. By integrating multicomplex pharmacophore modeling, molecular dynamics, protein-ligand interaction energy analysis, and free energy calculations, this study offers a framework for identifying novel anticancer agents.http://www.sciencedirect.com/science/article/pii/S2667022424003530Structure-based drug designmulticomplex-based pharmacophore modelingmolecular dynamics simulationsMM/PBSA-based binding free energy |
| spellingShingle | Nisarg Rana Priyanka Solanki Rukmankesh Mehra Anu Manhas Identification of natural compound inhibitors for substrate-binding site of MTHFD2 enzyme: Insights from structure-based drug design and biomolecular simulations Chemical Physics Impact Structure-based drug design multicomplex-based pharmacophore modeling molecular dynamics simulations MM/PBSA-based binding free energy |
| title | Identification of natural compound inhibitors for substrate-binding site of MTHFD2 enzyme: Insights from structure-based drug design and biomolecular simulations |
| title_full | Identification of natural compound inhibitors for substrate-binding site of MTHFD2 enzyme: Insights from structure-based drug design and biomolecular simulations |
| title_fullStr | Identification of natural compound inhibitors for substrate-binding site of MTHFD2 enzyme: Insights from structure-based drug design and biomolecular simulations |
| title_full_unstemmed | Identification of natural compound inhibitors for substrate-binding site of MTHFD2 enzyme: Insights from structure-based drug design and biomolecular simulations |
| title_short | Identification of natural compound inhibitors for substrate-binding site of MTHFD2 enzyme: Insights from structure-based drug design and biomolecular simulations |
| title_sort | identification of natural compound inhibitors for substrate binding site of mthfd2 enzyme insights from structure based drug design and biomolecular simulations |
| topic | Structure-based drug design multicomplex-based pharmacophore modeling molecular dynamics simulations MM/PBSA-based binding free energy |
| url | http://www.sciencedirect.com/science/article/pii/S2667022424003530 |
| work_keys_str_mv | AT nisargrana identificationofnaturalcompoundinhibitorsforsubstratebindingsiteofmthfd2enzymeinsightsfromstructurebaseddrugdesignandbiomolecularsimulations AT priyankasolanki identificationofnaturalcompoundinhibitorsforsubstratebindingsiteofmthfd2enzymeinsightsfromstructurebaseddrugdesignandbiomolecularsimulations AT rukmankeshmehra identificationofnaturalcompoundinhibitorsforsubstratebindingsiteofmthfd2enzymeinsightsfromstructurebaseddrugdesignandbiomolecularsimulations AT anumanhas identificationofnaturalcompoundinhibitorsforsubstratebindingsiteofmthfd2enzymeinsightsfromstructurebaseddrugdesignandbiomolecularsimulations |